Delivery Order SPE2DB20D2104-SPE2DB25FMVGF
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $16,162.26, is for the delivery of granisetron HCL 1 mg tablet units. It is a firm fixed-price delivery order contract with a completion date of December 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Granisetron Hydrochloride 1 mg Tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $3,346.21, and has an ultimate completion date of October 19, 2023. The contract is not designated with a set-aside, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company,...
- This federal contract award is for the delivery of Granisetron HCL 1 mg Tablet UD 20s, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $18,162.43 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of May 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $16,551.54, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) Troop Support to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the supply of 4,564,073,988 units of the pharmaceutical product Granisetron HCL 1 MG Tablet UD 20S. Amerisourcebergen Drug Corp, through its Corporate Office located in Conshohocken,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,593.13 firm-fixed-price delivery order is for the supply of granisetron hydrochloride 1 mg tablets to support federal healthcare programs. The award is a task order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December...
- This federal contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract. The $20,983.81 firm-fixed-price contract is for the supply of Granisetron Hydrochloride 1 mg Tablets, a medication used to prevent nausea and vomiting associated with chemotherapy. The award has a completion date of September 9, 2024 and does not utilize a socioeconomic set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,409.90 firm fixed-price delivery order is for the supply of 4566796601 - GRANISETRON HCL 1 MG TABLET UD 20S, with a completion date of December 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $13,674.04 firm fixed price contract is for the supply of Granisetron Hydrochloride 1 mg tablets to support military treatment programs and facilities. No set-aside designation was used. AmerisourceBergen Drug Corp, as a prime contractor, has a history of providing a range of pharmaceutical products and medical supplies to the DLA...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,698.53 firm fixed-price delivery order is for the supply of Granix 300 mcg TBO, a specialty medication. The contract has an ultimate completion date of July 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,146.69, is a delivery order contract with a firm fixed price pricing type. The contract is not set-aside and has an ultimate completion date of July 18, 2025. The contract provides for the delivery of pharmaceutical products, including medications such as Gralise ER 600...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMVGFDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $4,622.80, for the supply of Granisetron Hydrochloride 1 mg Tablets. The contract has an ultimate completion date of July 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The contract award is not designated as a set-aside.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 7/11/25 |